Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

SNY – Sanofi

Sanofi
SNY
$47.85
Name : Sanofi
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $117,021,474,816.00
EPSttm : 2.92
finviz dynamic chart for SNY
Sanofi
$47.85
1.08%
$0.52

Float Short %

0.18

Margin Of Safety %

26

Put/Call OI Ratio

0.82

EPS Next Q Diff

0.77

EPS Last/This Y

2.1

EPS This/Next Y

0.45

Price

47.86

Target Price

65.59

Analyst Recom

1.68

Performance Q

-12.86

Relative Volume

0.99

Beta

0.48

Ticker: SNY




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02SNY49.161.091.9840935
2025-06-03SNY49.21.080.3740852
2025-06-04SNY49.511.071.5440903
2025-06-05SNY49.791.060.3140635
2025-06-06SNY50.51.051.0240900
2025-06-09SNY49.741.053.8941010
2025-06-10SNY49.91.065.3641133
2025-06-11SNY49.711.101.7042216
2025-06-12SNY50.851.131.7646028
2025-06-13SNY49.681.140.5546360
2025-06-16SNY49.441.140.1546469
2025-06-17SNY48.241.010.0846735
2025-06-18SNY47.610.910.5049183
2025-06-20SNY47.890.900.7449157
2025-06-23SNY48.220.710.5234427
2025-06-24SNY48.420.710.1635050
2025-06-25SNY47.790.820.4237006
2025-06-26SNY48.360.820.9937086
2025-06-27SNY47.870.820.2837357
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02SNY49.17-2.93555.84.61
2025-06-03SNY49.19-2.93554.74.61
2025-06-04SNY49.49-2.93953.84.61
2025-06-05SNY49.76-2.93970.84.61
2025-06-06SNY50.49-2.94097.84.61
2025-06-09SNY49.75-2.93798.64.61
2025-06-10SNY49.88-2.93936.94.61
2025-06-11SNY49.73-2.93734.34.60
2025-06-12SNY50.83-2.94112.34.60
2025-06-13SNY49.69-1.93714.24.62
2025-06-16SNY49.44-1.93771.84.62
2025-06-17SNY48.23-1.93608.24.62
2025-06-18SNY47.62-1.93600.94.62
2025-06-20SNY47.86-2.83942.34.62
2025-06-23SNY48.18-2.83962.84.62
2025-06-24SNY48.44-2.84049.14.62
2025-06-25SNY47.78-2.83824.14.62
2025-06-26SNY48.35-2.84169.94.62
2025-06-27SNY47.86-2.84036.64.62
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02SNY0.00-1.200.15
2025-06-03SNY0.00-1.200.15
2025-06-04SNY0.00-1.200.15
2025-06-05SNY0.00-1.200.15
2025-06-06SNY0.00-1.200.15
2025-06-09SNY0.00-1.410.15
2025-06-10SNY0.00-1.410.15
2025-06-11SNY0.00-1.410.19
2025-06-12SNY0.00-1.410.19
2025-06-13SNY0.00-1.410.19
2025-06-16SNY0.00-1.410.19
2025-06-17SNY0.00-1.410.19
2025-06-18SNY0.00-1.410.19
2025-06-20SNY0.00-1.410.19
2025-06-23SNY0.00-1.140.19
2025-06-24SNY0.00-1.140.19
2025-06-25SNY0.00-1.140.19
2025-06-26SNY0.00-1.140.18
2025-06-27SNY0.00-1.140.18
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.94

Avg. EPS Est. Current Quarter

0.91

Avg. EPS Est. Next Quarter

1.71

Insider Transactions

Institutional Transactions

-1.14

Beta

0.48

Average Sales Estimate Current Quarter

9866

Average Sales Estimate Next Quarter

12873

Fair Value

60.16

Quality Score

88

Growth Score

90

Sentiment Score

71

Actual DrawDown %

20.4

Max Drawdown 5-Year %

-33.5

Target Price

65.59

P/E

19.98

Forward P/E

9.5

PEG

1.51

P/S

2.62

P/B

1.49

P/Free Cash Flow

14.66

EPS

2.39

Average EPS Est. Cur. Y​

4.62

EPS Next Y. (Est.)

5.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.54

Relative Volume

0.99

Return on Equity vs Sector %

-19.8

Return on Equity vs Industry %

-28

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

4036.6
Sanofi
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 82878
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as an strategic alliance with the Department of Health – Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
stock quote shares SNY – Sanofi Stock Price stock today
news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025
marketwatch SNY – Sanofi yahoo finance google finance
stock history SNY – Sanofi invest stock market
stock prices SNY premarket after hours
ticker SNY fair value insiders trading